AJJ Medtech 584

SGD 0.003 -33.33% 0.00 Updated 13 Nov 2026, 17:16 SGT

Company profile

The business, the people and the ownership behind AJJ Medtech.

Business overview

About the company

AJJ Medtech operates healthcare products, healthcare services and digital healthcare businesses. Its strategic areas include intelligent care robotics, renal care and digital healthcare systems.

Annual Report 2025 ↗ Reviewed 2026-10-23 · Source dated 2026-04-14. PDF p. 119

Listed security

Company & listing

Full Company Name
AJJ MEDTECH HOLDINGS LIMITED
Trading Currency
SGD
Website
www.ajjmedtech.com.sg
Listing
Listed on 21 December 1994 on SGX Sesdaq
Listing Board
CATALIST
ISIN Code
SG0584008601

Board & management

Leadership

Zhang Jian

Chairman and Executive Director

Zhao Xin

Chief Executive Officer and Executive Director

Chong Eng Wee

Independent Director

Tan Lye Heng Paul

Independent Director

Roles listed in Annual Report 2025; current appointments are not independently verified.

Holdings

Ownership

ZHANG JIAN

Direct interest 361,616,714.00 shares (21.13%); deemed interest 87,428,571.00 shares (5.11%)

As recorded in the Register of Substantial Shareholders; as at 18 March 2026

ZHANG YULEI

Direct interest 87,428,571.00 shares (5.11%); deemed interest – (–)

As recorded in the Register of Substantial Shareholders; as at 18 March 2026

Total interests include direct and deemed holdings and may overlap across holders. These percentages should not be added together.

Registered & depository holders 20 holders

Registered holdings, including nominees and depositories; these do not establish ultimate beneficial ownership. As reported at 18 March 2026 · PDF p. 123

Registered holderInterestShares / unitsSource
ZHANG JIAN361,616,714 shares; 21.13PDF p. 12318 March 2026
DBS NOMINEES PTE LTD93,030,354 shares; 5.44PDF p. 12318 March 2026
ZHANG YULEI87,428,571 shares; 5.11PDF p. 12318 March 2026
LIU YUNHUA70,000,000 shares; 4.09PDF p. 12318 March 2026
HUANG QIANG61,408,114 shares; 3.59PDF p. 12318 March 2026
ZHANG YUNHAI58,037,143 shares; 3.39PDF p. 12318 March 2026
KOH YEW CHOO48,644,000 shares; 2.84PDF p. 12318 March 2026
ZHAO XIN39,773,000 shares; 2.32PDF p. 12318 March 2026
MOOMOO FINANCIAL SINGAPORE PTE. LTD.35,033,944 shares; 2.05PDF p. 12318 March 2026
ONG BEE HUAT30,000,000 shares; 1.75PDF p. 12318 March 2026
PHILLIP SECURITIES PTE LTD29,651,629 shares; 1.73PDF p. 12318 March 2026
UOB KAY HIAN PTE LTD26,354,700 shares; 1.54PDF p. 12318 March 2026
CHUA JUNE GAY23,160,422 shares; 1.35PDF p. 12318 March 2026
BAI HONGFU22,637,500 shares; 1.32PDF p. 12318 March 2026
MAYBANK SECURITIES PTE. LTD.22,043,753 shares; 1.29PDF p. 12318 March 2026
KOH TIAK CHYE18,000,000 shares; 1.05PDF p. 12318 March 2026
UNITED OVERSEAS BANK NOMINEES (PRIVATE) LIMITED16,363,000 shares; 0.96PDF p. 12318 March 2026
GOH BEE YONG16,000,000 shares; 0.93PDF p. 12318 March 2026
ANG AH LEK @AN AH LEK14,000,000 shares; 0.82PDF p. 12318 March 2026
TAN KIM YEOW14,000,000 shares; 0.82PDF p. 12318 March 2026

Group structure

Main operating subsidiaries

CompanyMarketOwnership interest
AJJ Healthcare Management Pte. Ltd.1Held by the Company; effective interests 2025 and 2024 Singapore; effective equity interest held by the Company: 100% (2025), 100% (2024); Investment holding and management consultancy services for healthcare organisations
W Property Management Pte. Ltd.1, 2Held by the Company; effective interests 2025 and 2024 Singapore; effective equity interest held by the Company: 100% (2025), 100% (2024); Real estate leasing and management
ESO Health Care Pte. Ltd.1, 2Held by the Company; effective interests 2025 and 2024 Singapore; effective equity interest held by the Company: 100% (2025), 100% (2024); Investment holding, nurseries and kindergartens
Shanghai Longjian Hospital Management Co., Ltd.2Held by the Company; effective interests 2025 and 2024 China; effective equity interest held by the Company: 51% (2025), 51% (2024); Hospital management, medical technology, biotechnology, technology development and health management consulting
HIFU Suntec Pte. Ltd.1, 2Held through AJJ Healthcare Management Pte. Ltd.; effective interests 2025 and 2024 Singapore; effective equity interest held by AJJ Healthcare Management Pte. Ltd.: 80% (2025), 80% (2024); Conduct research and development of medical technologies, manufacture and repair of irradiation and electromedical of HIFU machine and other medical equipment
Quest Asia Technologies Pte. Ltd.1Held through AJJ Healthcare Management Pte. Ltd.; effective interests 2025 and 2024 Singapore; effective equity interest held by AJJ Healthcare Management Pte. Ltd.: 100% (2025), 100% (2024); Wholesale of medical, professional, scientific and precision equipment

Ownership interests and geographic information follow the annual report. Comparative years and footnote markers retain the report’s notation.

Senior executives

Key management

Key management

ItemValuePeriod / scopeSource
Ms Zhang Yulei Chief Strategy Officer AJJ Medtech Holdings Limited PDF p. 9
Mr William Ong Hon Hsiang Executive Director and Chief Executive Officer of AJJ Healthcare Management Pte. Ltd. AJJ Healthcare Management Pte. Ltd. PDF p. 9
Mr Chua June Gay Leslie Director of Corporate Partnerships AJJ Healthcare Management Pte. Ltd. PDF p. 9
Dr Tan Weijie Director of Business Development AJJ Healthcare Management Pte. Ltd. PDF p. 9
Mr Tan Kee Hong Group Financial Controller; Company Secretary AJJ Medtech Holdings Limited · As at 2025-09-09 PDF p. 59

Extracted from Annual Report 2025 and checked against the cited pages; see the original report for full context.

Shareholding statistics

Share capital & shareholders

Shareholding distribution

ItemValuePeriod / scopeSource
Grand Total 2,720 shareholders Number of shareholders as at 18 March 2026 · As at 2026-03-18 PDF p. 123
1 – 99 4 holders; 0.15% of holders; 33 shares; 0.00% of shares Size of shareholdings band, as at 18 March 2026 · As at 2026-03-18 PDF p. 123
100 – 1,000 289 holders; 10.63% of holders; 277,858 shares; 0.02% of shares Size of shareholdings band, as at 18 March 2026 · As at 2026-03-18 PDF p. 123
1,001 – 10,000 791 holders; 29.08% of holders; 4,498,200 shares; 0.26% of shares Size of shareholdings band, as at 18 March 2026 · As at 2026-03-18 PDF p. 123
10,001 – 1,000,000 1,495 holders; 54.96% of holders; 232,274,083 shares; 13.57% of shares Size of shareholdings band, as at 18 March 2026 · As at 2026-03-18 PDF p. 123
1,000,001 and above 141 holders; 5.18% of holders; 1,474,488,126 shares; 86.15% of shares Size of shareholdings band, as at 18 March 2026 · As at 2026-03-18 PDF p. 123

Share capital

ItemValuePeriod / scopeSource
Grand Total 1,711,538,300 shares Total number of shares held by shareholders as at 18 March 2026 · As at 2026-03-18 PDF p. 123

Free float

ItemValuePeriod / scopeSource
PERCENTAGE OF SHAREHOLDING HELD IN THE NAME OF PUBLIC approximately 71.44% As at 18 March 2026, on the basis of information available to the Company · As at 2026-03-18 PDF p. 123
Rule 723 compliance statement the Company has complied with the Rule 723 of the Catalist Rule As at 18 March 2026 · As at 2026-03-18 PDF p. 123

Extracted from Annual Report 2025 and checked against the cited pages; see the original report for full context.

Related parties, people & properties

Other disclosures

Related party transactions

ItemValuePeriod / scopeSource
Dr Zhang Jian (Lender) interest-free loan S$500,000 Company, FY2025 PDF p. 68
Fees paid to company in which the Company’s key management personnel has a financial interest 45 S$’000 Group 2025 (also Group 2024: 45; Company 2025: 45; Company 2024: 45) PDF p. 115

Contingent liabilities

ItemValuePeriod / scopeSource
Unpaid salaries to employees S$132,000 Group, as of 31 December 2025 · As at 2025-12-31 PDF p. 115

Director remuneration

ItemValuePeriod / scopeSource
Dr Zhang Jian 625,341 S$ FY2025 total, S$ PDF p. 58
Ms Zhao Xin 313,231 S$ FY2025 total, S$ PDF p. 58
Mr Chong Eng Wee 45,600 S$ FY2025 total, S$ PDF p. 58
Dr Toh Lim Kai 43,600 S$ FY2025 total, S$ PDF p. 58
Mr Tan Lye Heng Paul 43,600 S$ FY2025 total, S$ PDF p. 58
total remuneration paid to the key management personnel S$1,001,852 Five key management personnel (not directors/CEO), FY2025 PDF p. 59

Subsequent events

ItemValuePeriod / scopeSource
Supply contract for biodegradable medical consumables approximately S$3.0 million Group, after reporting date PDF p. 122
Elderly care robotics strategic collaboration On 2 February 2026, the Company announced certain strategic collaboration and development initiatives relating to elderly care robotics. Company, after reporting date PDF p. 122

Outlook

ItemValuePeriod / scopeSource
Looking Ahead Future healthcare systems are expected to increasingly rely on intelligent healthcare infrastructure, including robotics, digital healthcare systems and artificial intelligence technologies. Letter from Chairman & CEO PDF p. 6

Extracted from Annual Report 2025 and checked against the cited pages; see the original report for full context.

Source: Annual Report 2025 ↗

Corporate information

Registration & contacts

Incorporated In
SINGAPORE
Incorporated On
15 Sep 1984
Email
[email protected]
Telephone
65 6235 5091
Fax
65 6235 5513
Registered Office
8 Commonwealth Lane
#02-04 Grande Building
Singapore 149555
Secretary
Tan Kee Hong
Registrar / Transfer Agent
TRICOR BARBINDER SHARE REGISTRATION SERVICES
Registrar Address
9 Raffles Place, Republic Plaza Tower I #26-01, Singapore 048619
Auditors
UHY LEE SENG CHAN & CO.
Other Stock Exchange Listings
*SINGAPORE EXCHANGE (CATALIST)
Country
SINGAPORE
Security Type
stocks